INTRODUCTION
Cerebral white matter injury in premature very-low-birth-weight infants is an important cause of cerebral palsy and cognitive deficit. 1 Cranial ultrasonography has identified two major patterns of neonatal white matter injury -periventricular hemorrhagic infarction (PHI) and periventricular leukomalacia (PVL). However, controversy exists regarding their pathogenesis and potential interrelationship. 1 -3 Theories on the pathogenesis of PHI stress the importance of the presence of an ipsilateral intraventricular hemorrhage that obstructs the periventricular venous drainage leading to a unilateral, or markedly asymmetric, venous infarction. 4, 5 In contrast, PVL is considered by many to be an ischemic lesion resulting in small, multiple, bilateral, periventricular cysts typically in arterial watershed areas. 6 -8 Despite a great deal of experimental and clinical research supporting pathogenetic differences between PHI and PVL, a growing body of data suggests that these two white matter lesions are different manifestations of a more global brain injury. A possible mechanism of this global injury has been provided by recent studies showing an association between maternal chorioamnionitis and development of cystic white matter lesions and cerebral palsy. 9 -11 The paradigm of neonatal brain injury caused by fetal inflammation secondary to maternal infection is further supported by the findings of increased pro-inflammatory cytokines in amniotic fluid and umbilical cord blood of infants developing white matter lesions. 12 -14 However, the predominant form of white matter injury described in these reports has been cystic PVL. It is unclear if there is a similar relationship between a fetal inflammatory state and PHI.
Previous studies have suggested that infants subsequently developing PVL are more mature and more clinically stable than their counterparts developing PHI. 10, 11 These clinical observations may be explained by experimental studies showing that fetal lamb
OBJECTIVE:
To examine potential differences in clinical risk factors, including indices of hemodynamic and respiratory functions, of premature infants developing periventricular hemorrhagic infarction ( PHI ) or periventricular leukomalacia ( PVL ).
STUDY DESIGN:
Indices of hemodynamic stability and respiratory function were measured prospectively during the first week of life in a cohort of 100 premature infants with respiratory distress. Maternal history was retrospectively reviewed. These data were correlated with cranial ultrasonography using one -way ANOVA, Bonferroni multiple comparisons, and Wilcoxon rank sum tests. Longitudinal analysis was performed using Generalized Estimating Equations.
RESULTS:
Fifty -two infants with normal cranial ultrasound studies were compared to 12 with PHI and 9 with PVL. Infants developing PHI had significantly lower birth weights, lower Apgar scores, were more often male and multiple gestations, and required more vasopressor support than infants with normal ultrasound studies. Infants with PHI had significantly worse indices of respiratory function than either normal infants or those with PVL. PVL was significantly associated with maternal chorioamnionitis, whereas PHI was not.
CONCLUSION:
These data suggest that there are important differences in the pathogenesis of PHI and PVL. A clear understanding of these differences is required before future preventive strategies can be formulated. Original Article
exposure to endotoxin results in dramatic improvements in postnatal lung function. 15 -17 Therefore, the factors that predispose infants to PVL may be operative before birth, i.e., exposure to inflammatory mediators, whereas the degree of immaturity, the events of delivery, and the degree of neonatal illness may be more important in the pathogenesis of PHI.
We prospectively studied a cohort of high-risk infants by correlating indices of hemodynamic stability and respiratory function during the first 7 days of life with the results of their cranial ultrasound examinations. The documentation of differences in risk factors and clinical illness of infants subsequently developing PHI and PVL may provide insight into their mechanism(s) of pathogenesis.
METHODS

Patient Population
The study was approved by the Eastern Virginia Medical School Institutional Review Board, and parental consent was obtained prior to enrolment. Patients were considered for enrollment based on the following criteria: (1) gestational age 32 weeks, (2) birth weight <1500 g at birth, (3) absence of major congenital malformations, and (4) ventilatory support for respiratory distress syndrome.
Maternal histories were reviewed for prior illness, the diagnosis of pregnancy-induced hypertension, the administration of antenatal steroids, the type of delivery, and specific attention was given to factors suggesting the presence of chorioamnionitis, e.g., (1) rupture of membranes !18 hours prior to delivery, (2) maternal temperature of !388C prior to delivery, (3) abdominal tenderness, and (4) bacterial vaginosis or vaginal discharge. A diagnosis of maternal chorioamnionitis was made if there were two or more of these clinical criteria present, or if there was a finding of acute chorioamnionitis on examination of the placenta. Routine histologic examination of the placenta was not performed in all cases. Newborn data included gestational age, birth weight, gender, and Apgar scores. Admission temperature, heart rate, blood pressure, and hematocrit were recorded, as well as the number of surfactant doses administered. Surfactant was administered to infants with the typical ground glass appearance of respiratory distress syndrome on chest radiograph and requiring greater than 40% oxygen.
Indices of Hemodynamic Stability
The degree of hemodynamic stability was determined by recording the lowest mean arterial blood pressure, the requirement for the administration of normal saline for volume expansion, and the requirement of vasopressor support (dopamine and/or dobutamine) during the first hours after admission (the first partial day of admission, day 0) and daily for 7 days. Hypotension was defined as a sustained mean arterial blood pressure (mm Hg) less than the gestational age in weeks. Typically, hypotension was treated with up to three boluses of normal saline. Persistent hypotension was further treated with a dopamine infusion, and if necessary, dobutamine.
Indices of Respiratory Function
Maximal oxygen requirement (FiO 2 ) and maximal mean airway pressure (MAP) were recorded for the first partial day of admission (day 0) and daily for the first 7 days of life. Oxygenation index (OI), alveolar-to-arterial oxygen tension gradient (A-aDO 2 ), and the arterial-to-alveolar oxygen tension ratio (a/A ratio) were calculated each day for the first seven 7 of life, using the standard formula:
The arterial blood gas values associated with the highest FiO 2 requirement during the time interval in question were used in the calculations. When multiple blood gases were obtained with the same FiO 2 , the blood gas with the lowest P a O 2 was used in the calculations. The a/A ratio was also calculated using the P a O 2 associated with the highest FiO 2 .
Cranial Ultrasonography
Cranial ultrasound examinations were performed at 4 to 7 days of life and, if abnormal, weekly thereafter, using Logiq 500 MD (General 
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Electric Medical Systems, Tokyo, Japan) with a 6-MHz sector and a 7-MHz linear probe. If the initial examination was normal and the infant remained clinically stable, a second ultrasound was performed at 2 months of age or prior to hospital discharge. All ultrasound studies were reviewed by two investigators certified in pediatric neurosonology, unaware of the clinical details. Standard criteria were used to diagnose intraventricular hemorrhage. 6 Periventricular white matter lesions were classified as PHI or PVL using previously published criteria. 18 Criteria for the diagnosis of PHI included (1) the appearance within the first week of life of a large unilateral or clearly asymmetric echodensity in the periventricular white matter in association with an ipsilateral intraventricular hemorrhage ( Figure  1A) , and (2) the evolution of the echodensity into a single (or few) large cyst(s) communicating with the lateral ventricle ( Figure 1B) .
Criteria for the diagnosis of PVL included (1) the development of bilateral echodensities or ''flares'' at the lateral border of the lateral ventricles with minimal or no associated intraventricular hemorrhage (Figure 2A) , and (2) the evolution of the echodensities into multiple small cysts not communicating with the lateral ventricles ( Figure 2B ). Infants subsequently developing significant ventriculomegaly with or without previous periventricular ''flare'' or echodensity were included in the PVL group. 19 -21 Infants with ventriculomegaly associated with hemorrhage and rapid head growth were included in the PHI group. Infants with intraventricular hemorrhage only, or transient periventricular echodensities without subsequent white matter loss, were not included in the analysis. 
RESULTS
From November 1998 to September 1999, 100 premature very-lowbirth-weight infants were enrolled in the study and followed in our neonatal intensive care unit. The median gestational age was 27 weeks (range 23 to 32) and the mean birth weight was 975 g ( ±28). Seventy-six patients were inborn and 57 were female. The median 1-and 5-minute Apgar scores were 5 (range 0 to 9) and 7 (range 1 to 9), respectively. Two infants expired prior to the initial ultrasound examination and were excluded from the study. Of the remaining 98 infants, 52 had normal ultrasound studies, 9 developed intraventricular hemorrhage only, and 16 had subtle periventricular ''flares'' or echodensities without subsequent white matter loss. Twenty-one infants had some form of white matter loss including 12 with PHI and 9 with PVL. The PVL group included four with cystic PVL, three with ventriculomegaly associated with prior white matter echodensity, and two with ventriculomegaly not associated with previous ultrasound abnormality. Seven infants in the PHI group developed posthemorrhagic hydrocephalus, of which three expired, and the four remaining infants required the placement of a ventriculoperitoneal shunt. A summary of the cranial ultrasound results is shown in Table 1 .
Characteristics of the 52 patients with normal ultrasounds, the 12 patients with PHI, and the 9 patients with PVL are shown in Table 2 . Both PHI and PVL were associated with significantly lower gestational age and Apgar scores at 5 minutes. In addition, infants developing PHI had significantly lower birth weights, were more often male, were more often products of multiple gestations, and had lower 1-minute Apgar scores than normal infants. Infants developing PVL had a significantly greater incidence of maternal chorioamnionitis than infants with normal ultrasounds or infants developing PHI. No significant differences were noted among the three groups with regard to the administration of antenatal steroids, the diagnosis of PIH, or vaginal versus cesarean delivery.
Comparisons of the admission data are shown in Table 3 . No significant differences were seen among the three groups at the time of admission with regard to temperature, heart rate, hematocrit, or blood pressure. A similar percentage of patients in each group received surfactant; however, patients developing PHI and PVL required a significantly greater number of surfactant doses.
The indices of hemodynamic function are shown in Figure 3 . No significant differences were noted among the groups for the lowest mean blood pressure during the first 7 days of life. However, comparing infants day by day, a significantly greater percentage of infants developing PHI required volume expansion on the day of admission (p<0.03) than did normal infants. Infants with PHI also required more vasopressor support on the day of admission (p<0.001), day 1 of life (p=0.001), and day 2 of life (p=0.002). Longitudinal analysis showed a significant difference in vasopressor support between the PHI group and both the normal and PVL groups. Figure 4 compares the respiratory indices of the three groups. No differences were noted between the normal and the PVL group. In fact, the PVL group tended to closely mirror the normal group in all parameters examined. In contrast, the patients subsequently developing PHI had worse indices of respiratory function. This difference reached statistical significance in the day-by-day comparison when the A-aDO 2 was compared to both the normal and the PVL group (p<0.01). Longitudinal analysis showed significant differences in maximal FiO 2 , MAP, OI, A-aDO 2 , and a/A ratio between infants with PHI and normal infants (p<0.03), whereas maximal FiO 2 was significantly different between infants with PHI and those with PVL.
DISCUSSION
An important and sometimes controversial issue for this and similar studies is the question of the capability of ultrasound to make a reliable diagnosis of the various types of brain lesions seen in premature infants. Cerebral white matter injury, especially PVL, is certainly a diagnosis best made at autopsy. Echodensities seen on ultrasound may represent edema, vascular congestion, or ischemic tissue, which may or may not become hemorrhagic. However, the ultrasound patterns of PHI and PVL described above have been commonly and consistently noted in previous studies 4, 8, 10, 22 and correlate well with autopsy findings, with the exception of diffuse, non-cystic PVL. 19 This non-cystic form of PVL may be associated with normal neonatal ultrasound findings or seen as transient or persistent periventricular ''flares'' or echodensities. White matter loss associated with diffuse non-cystic PVL may be detectable later by ultrasound in the form of ventriculomegaly or hydrocephalus ex vacuo, and for this reason, these infants were placed in the PVL group. 21 Unfortunately, with present ultrasound technology, more subtle, diffuse, non-cystic PVL not associated with secondary ventriculomegaly could be missed. With this limitation in mind, we chose to compare infants with normal ultrasound studies to those infants with evidence of parenchymal loss, either in the form of cysts or significant ventriculomegaly. 20, 21 The timing of ultrasound examinations is also an important issue. Although brain injury can occur at any point during pregnancy, labor, delivery, or neonatal period, a number of clinical studies show that the majority of cerebral white matter lesions or their antecedents are first detectable in the immediate newborn period. 6, 23 If PHI is thought of as a complication of IVH, then the timing of the onset of IVH is pertinent to this discussion. Forty to 50% of IVH occurs in the first day of life and 90% is detected by the third day of life with the peak time of occurrence of PHI on days 3 to 5. 6 Shuman and Selednik 23 have noted that PVL is diagnosed at autopsy more often in infants surviving at least 6 days or more, implying that some postnatal time is necessary after the initial insult for the pathologic manifestation of PVL to develop. The sequelae of PVL depend on the extent of the initial lesion and the time after the acute event.
6 Periventricular cysts can be noted as early as 1 to 3 weeks, and may gradually constrict over the next several weeks to months with the loss of white matter becoming manifest as enlargement of the lateral ventricles. Based on these patterns of evolution, we used a modified ultrasound surveillance protocol for the detection of intracranial lesions by Perlman and Rollins. 24 An initial ultrasound study at 4 to 7 days of life was expected to detect 90% of the hemorrhagic lesions of IVH and PHI, as well as the early, more subtle periventricular echodensities of PVL. Any abnormality detected was followed with weekly ultrasounds. If the initial study was normal, then a repeat ultrasound was performed at 8 weeks to look for cystic PVL or evidence of ventriculomegaly. Although a second ultrasound study in the interval could have potentially provided additional information, we felt that significant echodense lesions or cysts developing after the initial ultrasound would be detectable later as periventricular echodensities, cystic PVL, or ventriculomegaly.
It is generally accepted that premature very-low-birth-weight newborns with respiratory distress syndrome are at risk for developing intraventricular hemorrhage and cerebral white matter lesions. 25, 26 Attempting to quantify this risk by grading the severity of lung disease by appearance of the chest radiograph is difficult and somewhat subjective. We felt that documentation of a combination of indices, including the maximal FiO 2 and MAP, with calculation of OI, A-aDO 2 , and a/A ratio, could provide a more objective measure of lung disease. Our calculations of indices of respiratory function compare favorably with values reported in a recent study of ventilated premature infants, 27 and our key findings were that infants subsequently developing PHI, while relatively similar in birth weight and gestational age, had significantly more hemodynamic instability and significantly more severe respiratory disease during the first week of life than infants developing PVL. In fact, the infants developing PVL closely mirrored the hemodynamic and respiratory indices of the more mature infants with normal ultrasound studies.
The exact relationship between respiratory disease and PHI remains unclear. Severe respiratory distress syndrome may be directly involved in the pathogenesis of intraventricular hemorrhage (with secondary PHI) by causing fluctuations in pH, p a O 2 , p a CO 2 , or by changes in intrathoracic pressure leading to an unstable cerebral blood flow. 28 -30 Alternatively, severe respiratory disease may represent a confounding variable and be a marker for susceptibility for brain injury, in light of the failure of surfactant to change the incidence of intraventricular hemorrhage. 31 Although previous studies have suggested that infants subsequently developing PHI tend to have lower gestational ages and birth weights than infants developing PVL, 10,32,33 we did not find this difference and feel it is unlikely that differences in respiratory function noted between the PHI and the PVL groups can be explained by differences in fetal maturity. We did, however, observe a significant increase in the incidence of chorioamnionitis in infants with PVL, a finding previously reported 10, 14, 34 and possibly explained by recent experimental studies showing that fetal lamb exposure to endotoxin results in dramatic improvements in postnatal lung function. 15 -17 Therefore, it is interesting to speculate that an in utero inflammatory state might enhance lung maturity while setting into motion a cascade of cytokine-mediated events leading to immature oligodendrocyte injury and the postnatal development of PVL. Potential differences in risk factors leading to the various forms of brain injury will be important in the formulation of future neuroprotective therapies.
